- Home
- CARV vs CLRB Comparison
CARV vs CLRB Comparison
Compare CARV & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- CLRB
- Stock Information
- Founded
- CARV 1948
- CLRB 2002
- Country
- CARV United States
- CLRB United States
- Employees
- CARV N/A
- CLRB N/A
- Industry
- CARV Savings Institutions
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- CLRB Health Care
- Exchange
- CARV Nasdaq
- CLRB Nasdaq
- Market Cap
- CARV 9.0M
- CLRB 10.7M
- IPO Year
- CARV 1994
- CLRB N/A
- Fundamental
- Price
- CARV $1.84
- CLRB $0.35
- Analyst Decision
- CARV
- CLRB Buy
- Analyst Count
- CARV 0
- CLRB 2
- Target Price
- CARV N/A
- CLRB $28.00
- AVG Volume (30 Days)
- CARV 15.7K
- CLRB 5.0M
- Earning Date
- CARV 02-12-2025
- CLRB 11-18-2024
- Dividend Yield
- CARV N/A
- CLRB N/A
- EPS Growth
- CARV N/A
- CLRB N/A
- EPS
- CARV N/A
- CLRB N/A
- Revenue
- CARV $28,323,000.00
- CLRB N/A
- Revenue This Year
- CARV N/A
- CLRB N/A
- Revenue Next Year
- CARV N/A
- CLRB N/A
- P/E Ratio
- CARV N/A
- CLRB N/A
- Revenue Growth
- CARV 9.41
- CLRB N/A
- 52 Week Low
- CARV $1.26
- CLRB $0.22
- 52 Week High
- CARV $2.39
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- CARV 52.53
- CLRB 21.73
- Support Level
- CARV $1.81
- CLRB $0.27
- Resistance Level
- CARV $1.89
- CLRB $0.33
- Average True Range (ATR)
- CARV 0.06
- CLRB 0.03
- MACD
- CARV -0.00
- CLRB 0.05
- Stochastic Oscillator
- CARV 50.00
- CLRB 96.46
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.